Mutations in the dark side of the genome cause leukemia
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia, the most common leukemia in1
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia, the most common leukemia in1
A study published in the New England Journal of Medicine (NEJM) shows that abnormal lung development before 40 years of age predisposes to a diagnos1
Researchers from IDIBAPS describe a molecular mechanism linking the development of type 2 diabetes with the malfunction of a cell organelle, the end1
Fingolimod, a drug used to treat multiple sclerosis, restores hippocampal synaptic plasticity and improves memory function. This is the main conclus1
Throughout 2014 IDIBAPS promoted several activities to publicize the research develop in its laboratories through the urban natural drawing (urban sk1
On Monday July 6 took place the Welcoming Ceremony at the Hospital Clínic for the students of nursing Ph doctorate of the EANS (European Academy of N1
Researchers from IDIBAPS and Hospital Clinic of Barcelona have created the first ontology that contains knowledge about Multiple Sclerosis (MS) to a1
A study conducted by researchers from IDIBAPS and Hospital Clinic of Barcelona has received the Arias Vallejo prize for the best communication in Ba1
The August Pi i Sunyer Biomedical Research Institute (IDIBAPS) launches the world's first biobank with ancient DNA from human samples, thanks to the1